Publications:72
Video Visit Available
Accepting New Patients
Mount Sinai DoctorsTreats Adults
Accepting New PatientsCelina Ang, MD
Internal Medicine, Cancer (Oncology)
No Patient Experience Ratings
Book an Appointment
About Me
Celina Ang, MD, is an Associate Professor of Medicine in the Division of Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai. Dr. Ang specializes in the care of patients with gastrointestinal malignancies, including esophageal, gastric, pancreatic, liver, biliary, colorectal, anal and adrenal cancers. She works with a dedicated multidisciplinary team to provide quality, evidence-based and patient-centered care to individuals with these cancers. In addition to using standard chemotherapies, targeted therapies and immunotherapy, Dr. Ang also offers hepatic arterial infusion pump chemotherapy for the treatment of patients with liver metastases.
Dr. Ang has a strong interest in clinical and translational research and is principle investigator on multiple clinical trials evaluating novel therapeutic agents and approaches in gastrointestinal malignancies. She has been lead author or co-author of over 75 peer-reviewed publications and book chapters. Since joining Mount Sinai in 2012, Dr. Ang has served as clinical preceptor and/or research mentor to more than 30 residents and fellows; she continues to train future generations of physicians and provide guidance on exemplary patient care.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
About Me
Celina Ang, MD, is an Associate Professor of Medicine in the Division of Hematology and Medical Oncology at the Icahn School of Medicine at Mount Sinai. Dr. Ang specializes in the care of patients with gastrointestinal malignancies, including esophageal, gastric, pancreatic, liver, biliary, colorectal, anal and adrenal cancers. She works with a dedicated multidisciplinary team to provide quality, evidence-based and patient-centered care to individuals with these cancers. In addition to using standard chemotherapies, targeted therapies and immunotherapy, Dr. Ang also offers hepatic arterial infusion pump chemotherapy for the treatment of patients with liver metastases.
Dr. Ang has a strong interest in clinical and translational research and is principle investigator on multiple clinical trials evaluating novel therapeutic agents and approaches in gastrointestinal malignancies. She has been lead author or co-author of over 75 peer-reviewed publications and book chapters. Since joining Mount Sinai in 2012, Dr. Ang has served as clinical preceptor and/or research mentor to more than 30 residents and fellows; she continues to train future generations of physicians and provide guidance on exemplary patient care.
Language
Position
Hospital Affiliations
- Mount Sinai Beth Israel
- Mount Sinai Morningside
- Mount Sinai Brooklyn
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
- Colon Cancer
- Colorectal Cancer
- Esophageal Cancer
- Gastrointestinal Cancers
- Liver Cancer
- Pancreatic Cancer
- Stomach Cancer
Education
MD, University of Western Ontario Faculty of Medicine & Dentistry
BSc, McGill University
Residency, Internal Medicine
Montreal General Hospital
Residency, Internal Medicine
Montreal General Hospital
Fellowship, Medical Oncology
McGill University Faculty of Medicine
Fellowship, Medical Oncology
McGill University Faculty of Medicine
Fellowship, Medical Oncology
Memorial Sloan-Kettering Cancer Center
Certifications
American Board of Internal Medicine
Awards
2011
Clinical training and research grant
Fibrolamellar Cancer Foundation
2010
Montreal General Hospital Foundation Research Award
2003
Dr. L. DeWitt Wilcox Award in Medical Research
Schulich School of Medicine & Dentistry, The University of Western Ontario
1997
James McGill Entrance Scholarship
McGill University
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Ruttenberg Treatment Center1470 Madison Avenue, 3rd Floor, New York, NY, 10029
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Perianal Fistulizing Crohn's Disease–Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus. Serre Yu Wong, Cathy Rowan, Elvira Diaz Brockmans, Cindy C.Y. Law, Elisabeth Giselbrecht, Celina Ang, Sergey Khaitov, David Sachar, Alexandros D. Polydorides, Leon Shin han Winata, Bram Verstockt, Antonino Spinelli, David T. Rubin, Parakkal Deepak, Dermot P.B. McGovern, Benjamin D. McDonald, Phillip Lung, Lilli Lundby, Amy L. Lightner, Stefan D. Holubar, Luke Hanna, Carla Hamarth, Jeroen Geldof, Anders Dige, Benjamin L. Cohen, Michele Carvello, Cristiana Bonifacio, Gabriele Bislenghi, Corina Behrenbruch, David H. Ballard, Emre Altinmakas, Shaji Sebastian, Phil Tozer, Ailsa Hart, Jean Frederic Colombel. Clinical Gastroenterology and Hepatology
- Hepatic decompensation is the major driver of mortality in patients with HCC treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment. Ciro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi, Salvatore Battaglia, Marco Enea, Bernhard Scheiner, Antonio D'Alessio, Giulia F. Manfredi, Bernardo Stefanini, Naoshi Nishida, Peter R. Galle, Kornelius Schulze, Henning Wege, Roberta Ciccia, Wei Fan Hsu, Caterina Vivaldi, Brooke Wietharn, Ryan Po Ting Lin, Angelo Pirozzi, Tiziana Pressiani, Andrea Dalbeni, Leonardo A. Natola, Alessandra Auriemma, Cristina Rigamonti, Michela Burlone, Alessandro Parisi, Yi Hsiang Huang, Pei Chang Lee, Celina Ang, Thomas U. Marron, Matthias Pinter, Jaekyung Cheon, Samuel Phen, Amit G. Singal, Anuhya Gampa, Anjana Pillai, Natascha Roehlen, Robert Thimme, Arndt Vogel, Noha Soror, Susanna Ulahannan, Rohini Sharma, David Sacerdoti, Mario Pirisi, Lorenza Rimassa, Chun Yen Lin, Anwaar Saeed, Gianluca Masi, Martin Schönlein, Johann Von Felden, Masatoshi Kudo, Alessio Cortellini, Hong Jae Chon, Calogero Cammà, David James Pinato. Hepatology
- Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab. Meng Wu, Claudia A.M. Fulgenzi, Antonio D'Alessio, Alessio Cortellini, Ciro Celsa, Giulia F. Manfredi, Bernardo Stefanini, Y. Linda Wu, Yi Hsiang Huang, Anwaar Saeed, Angelo Pirozzi, Tiziana Pressiani, Lorenza Rimassa, Martin Schoenlein, Kornelius Schulze, Johann von Felden, Yehia Mohamed, Ahmed O. Kaseb, Arndt Vogel, Natascha Roehlen, Marianna Silletta, Naoshi Nishida, Masatoshi Kudo, Caterina Vivaldi, Lorenz Balcar, Bernhard Scheiner, Matthias Pinter, Amit G. Singal, Joshua Glover, Susanna Ulahannan, Fredrich Foerster, Arndt Weinmann, Peter R. Galle, Neehar D. Parikh, Wei Fan Hsu, Alessandro Parisi, Hong Jae Chon, David J. Pinato, Celina Ang. JHEP Reports
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Ang has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Ang has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.